The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective monitoring of prostate specific membrane antigen (PSMA) –positive recurrent prostate cancer: Preliminary data from 6 months PSMA follow-up.
 
Ravi Madan
Research Funding - Bayer
 
Melissa Abel
No Relationships to Disclose
 
Esther Mena
No Relationships to Disclose
 
Liza Lindenberg
No Relationships to Disclose
 
Megan Hausler
No Relationships to Disclose
 
Monique Williams
No Relationships to Disclose
 
Amy Hankin
Stock and Other Ownership Interests - Amgen; Medtronic
 
Jeanny Aragon-Ching
Honoraria - Astellas Scientific and Medical Affairs Inc; Bristol-Myers Squibb; EMD Serono; Merck KGaA; Merck/Pfizer; Pfizer/EMD Serono
Consulting or Advisory Role - Algeta/Bayer; Amgen; AstraZeneca; AstraZeneca/MedImmune; AVEO; Bayer; Dendreon; EMD Serono; Exelixis; Immunomedics; Janssen Biotech; Merck; Pfizer; Pfizer/Myovant; Sanofi; Seagen
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Janssen-Ortho; Seattle Genetics/Astellas; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Algeta/Bayer; Astellas Pharma; Bristol Myers Squibb; Dendreon; EMD Serono
 
Laura Sena
No Relationships to Disclose
 
Russell Pachynski
Stock and Other Ownership Interests - Pixie Biosciences, Inc
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Dendreon; Eisai; Exelixis; Janssen Oncology; Macrogenics; Pfizer/EMD Serono; Sanofi; Tolmar Therapeutics
Speakers' Bureau - Bayer; Merck
Research Funding - Bristol Myers Squibb Foundation (Inst); Exelixis (Inst); Janssen Oncology; Pharmacyclics (Inst)
Patents, Royalties, Other Intellectual Property - Compositions comprising chemerin and methods of use thereof; Entitled: METHOD OF CELL-FREE DNA ANALYSIS TO IDENTIFY HIGH-RISK METASTATIC PROSTATE CANCER
Travel, Accommodations, Expenses - Genentech/Roche
 
Edwin Posadas
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Research Funding - PFizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
Expert Testimony - Shook, Hardy & Bacon L.L.P.
 
Helen Moon
Honoraria - EMD Serono (Inst); Pfizer/EMD Serono (Inst); Pfizer/NCCN (Inst)
Research Funding - Amgen (Inst); Apollomics (Inst); Arcus Biosciences (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); HUYA Bioscience International (Inst); Nektar (Inst); Pfizer (Inst); Prometheus; Revimmune (Inst); Seagen (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Aveo; Bayer; Genentech; Seagen
 
Marijo Bilusic
Research Funding - Hookipa Biotech (Inst); Lilly (Inst); Merck (Inst); Surface Oncology (Inst)
 
Philip Arlen
No Relationships to Disclose
 
Krishnan Patel
No Relationships to Disclose
 
Deborah Jolissaint
No Relationships to Disclose
 
Gregory Chesnut
No Relationships to Disclose
 
William Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); Propella Therapeutics (Inst); TRACON Pharma (Inst)
 
Fatima Karzai
No Relationships to Disclose
 
Peter Choyke
No Relationships to Disclose